Aeterna Wealth

Mutual funds holding Mankind Pharma shares

123 mutual fund schemes held Mankind Pharma shares in their latest portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹9,566 cr in all. The largest holders by value are SBI Large Cap Fund (1.9% of the fund), Nippon India Growth Mid Cap Fund (2.0% of the fund), HDFC Large Cap Fund (1.8% of the fund).

Against the month before, 2 schemes added Mankind Pharma as a new holding and 2 sold out of it completely.

New holders: Motilal Oswal Innovation Opportunities Fund, Invesco India Pharma and Healthcare Fund

Sold out: Canara Robeco Large Cap Fund, Canara Robeco Multi Cap Fund

By category: Index Fund (38), Sectoral/Thematic (24), Mid Cap (11), Large Cap (8), Flexi Cap (8), Large & Mid Cap (7).

13 actively managed schemes holding it are rated A+ or A on their track record, among them Bank Of India Flexi Cap Fund, Mirae Asset Healthcare Fund, SBI Healthcare Opportunities Fund, Nippon India Multi Asset Allocation Fund, Kotak Business Cycle Fund.

Every scheme holding Mankind Pharma, by value

SchemeRating% of fundValueChange
SBI Large Cap FundLarge CapC1.94%₹1,017 cr-0.01
Nippon India Growth Mid Cap FundMid CapB1.99%₹973 cr+0.04
HDFC Large Cap FundLarge CapC1.84%₹689 cr–
Nippon India Large Cap FundLarge CapC1.08%₹562 cr+0.04
Aditya Birla Sun Life Flexi Cap FundFlexi CapB1.85%₹525 cr–
Nippon India Pharma FundSectoral/ThematicC4.40%₹400 cr+0.02
Aditya Birla Sun Life Large Cap FundLarge CapB1.35%₹380 cr–
Franklin India Opportunities FundSectoral/ThematicB3.98%₹365 cr–
Mirae Asset Midcap FundMid CapB1.83%₹345 cr–
SBI Contra FundValue / ContraB0.74%₹329 cr+0.00
Franklin India Mid Cap FundMid CapC2.12%₹247 cr–
PGIM India Midcap FundMid CapB2.29%₹234 cr-0.17
Axis ELSS- Tax Saver FundELSSB0.76%₹231 cr–
Nippon India ELSS Tax Saver FundELSSB1.60%₹223 cr+0.01
Tata Mid Cap FundMid CapB3.42%₹195 cr–
Kotak Small Cap FundSmall CapC1.04%₹186 cr–
Nippon India Flexi Cap FundFlexi CapC1.91%₹172 cr+0.04
Edelweiss Mid Cap FundMid CapB0.90%₹168 cr–
Axis Midcap FundMid CapB0.48%₹161 cr–
UTI - Large Cap FundLarge CapC1.05%₹121 cr–
Aditya Birla Sun Life ELSS Tax Saver FundELSSB0.73%₹98 cr–
Aditya Birla Sun Life Large & Mid Cap FundLarge & Mid CapB1.54%₹84 cr–
Bank Of India Flexi Cap FundFlexi CapA2.67%₹84 cr–
Mirae Asset Healthcare FundSectoral/ThematicA2.19%₹78 cr-0.05
Franklin India Multi Cap FundMulti Cap–1.53%₹75 cr–
SBI Healthcare Opportunities FundSectoral/ThematicA1.23%₹75 cr-0.48
Mirae Asset Small Cap FundSmall Cap–1.15%₹65 cr–
Mirae Asset Flexi Cap FundFlexi CapB1.46%₹64 cr-0.01
Tata Large Cap FundLarge CapB2.45%₹63 cr–
Nippon India Multi Asset Allocation FundMulti Asset AllocationA0.35%₹63 cr–
SBI ESG Exclusionary Strategy FundSectoral/ThematicB1.24%₹62 cr-0.02
Tata Large & Mid Cap FundLarge & Mid CapC0.90%₹62 cr–
Kotak Pioneer FundSectoral/ThematicB1.27%₹53 cr–
Edelweiss Large & Mid Cap FundLarge & Mid CapB1.13%₹52 cr–
Kotak Business Cycle FundSectoral/ThematicA1.48%₹50 cr–
Invesco India Flexi Cap FundFlexi CapA+0.87%₹48 cr+0.24
Nippon India Balanced Advantage FundBalanced AdvantageA0.50%₹47 cr–
PGIM India Flexi Cap FundFlexi CapB0.85%₹47 cr-0.45
WhiteOak Capital Mid Cap FundMid CapB0.58%₹45 cr–
Edelweiss Focused FundFocusedC4.38%₹41 cr–

And 83 more schemes with smaller holdings.

Value: the scheme's assets under management × the stock's weight, approximate. Change: the weight against the previous month's portfolio, in percentage points; it moves with the share price as well as with buying and selling. Links go to each scheme's Regular plan.

Common questions

How many mutual funds hold Mankind Pharma shares?

123 schemes held Mankind Pharma in their latest monthly portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹9,566 cr in all.

Which mutual fund holds the most Mankind Pharma shares?

By value, SBI Large Cap Fund: about ₹1,017 cr, 1.94% of the fund.

Where does this data come from?

From the monthly portfolios that every fund house must publish by the 10th of the following month. Values are approximate: the fund's assets under management multiplied by the stock's weight in the portfolio.

This page lists which funds hold a stock. It is not a view on the stock or a recommendation to buy or sell it or any fund. Ratings describe past track records, not a forecast.

Free portfolio review

Send us your CAS and get a written report: which of your funds to keep, which to exit and when, where new SIPs should go, and what each change costs in tax.

Chat with us